What are the possible causes of postmenstrual bleeding and how should it be evaluated?

Postmenstrual Bleeding: Causes and Evaluation

Bleeding after your period has ended requires systematic evaluation to rule out underlying gynecological problems, with transvaginal ultrasound as the first-line imaging and consideration of structural lesions, hormonal contraceptive effects, infections, pregnancy, and pathologic uterine conditions.

Key Causes to Evaluate

If Using Hormonal Contraception

• Unscheduled bleeding is common and generally not harmful with extended or continuous combined hormonal contraceptives, implants, IUDs, or injectable contraceptives, particularly during the first 3-6 months of use 1
• Inconsistent contraceptive use, medication interactions, or cigarette smoking can trigger breakthrough bleeding 1

Structural and Pathologic Causes

When clinically indicated, consider:

• Endometrial polyps - common benign growths that increase with age and frequently cause abnormal bleeding 2, 3
• Uterine fibroids (leiomyomas) - particularly submucosal fibroids 1, 2
• Endometrial hyperplasia or malignancy - especially in women over 35 or those with risk factors like chronic anovulation and obesity 4
• Cervical pathology - polyps, cervicitis, or malignancy 1
• Sexually transmitted infections 1, 2
• Pregnancy - must be ruled out in reproductive-age women 1

Systemic Causes

• Coagulopathies - bleeding disorders 1, 4
• Thyroid dysfunction - hypothyroidism can cause abnormal bleeding 2, 4
• Ovulatory dysfunction - anovulation or oligo-ovulation 1, 4

Evaluation Algorithm

Step 1: Clinical Assessment

• Confirm bleeding source through speculum examination to distinguish uterine from vaginal, cervical, urological, or rectal bleeding 5
• Obtain pregnancy test (beta-hCG) in all reproductive-age women 1, 2
• Document medication history including hormonal contraceptives, anticoagulants, and other medications 1, 2
• Assess for STD risk factors and perform appropriate testing 1
• Perform Pap smear if due, and evaluate cervix for lesions 5

Step 2: Laboratory Testing (Selected Cases)

• Hemoglobin and iron levels if heavy bleeding present 2
• Thyroid-stimulating hormone if thyroid dysfunction suspected 1, 2
• Prolactin level if anovulation suspected 1

Step 3: Imaging

• Transvaginal ultrasound is the ideal first-line imaging study for evaluating postmenstrual bleeding 1, 2
• Saline infusion sonohysterography improves diagnostic accuracy when initial ultrasound shows endometrial abnormalities or polyps 2, 5
• MRI pelvis without and with contrast is appropriate if the uterus is incompletely visualized on ultrasound 1

Step 4: Tissue Diagnosis When Indicated

• Endometrial biopsy is indicated for:
  • Women over age 35 with abnormal bleeding 4
  • Younger women with risk factors for endometrial cancer (chronic anovulation, obesity) 4
  • Ultrasound findings showing endometrial thickening or abnormalities 2, 5
• Hysteroscopy with directed biopsy or polypectomy for suspected polyps or focal lesions 2, 3

Management Based on Findings

If Hormonal Contraceptive-Related

• Provide reassurance that unscheduled bleeding is generally not harmful and often decreases with continued use 1
• If treatment desired and no underlying pathology found:
  • NSAIDs for 5-7 days during bleeding episodes 1
  • Low-dose combined oral contraceptives or estrogen for 10-20 days (if medically eligible) 1
  • For continuous combined hormonal contraceptives: consider 3-4 day hormone-free interval (not during first 21 days, not more than once monthly) 1

If Structural Lesion Identified

• Endometrial polyps: Hysteroscopic removal if symptomatic 2, 3
• Submucous fibroids: Hysteroscopic resection 2
• Endometrial hyperplasia/malignancy: Refer for gynecologic oncology evaluation 1

If No Cause Found

• Expectant management is reasonable for mild symptoms 2
• Medical treatment options include progestin-only contraception, combined hormonal contraceptives, or levonorgestrel IUD 1, 2

Critical Pitfalls to Avoid

• Never perform digital pelvic examination before imaging in pregnancy until placenta previa and vasa previa are excluded 1
• Do not assume bleeding is benign in women over 35 without appropriate evaluation for endometrial pathology 4
• Do not attribute all bleeding to hormonal contraceptives without ruling out pregnancy, STDs, and structural lesions 1
• Inadequate endometrial sampling requires further evaluation with hysteroscopy rather than assuming benign pathology 5